PL365072A1 - Azole compounds as therapeutic agents for fungal infections - Google Patents

Azole compounds as therapeutic agents for fungal infections

Info

Publication number
PL365072A1
PL365072A1 PL01365072A PL36507201A PL365072A1 PL 365072 A1 PL365072 A1 PL 365072A1 PL 01365072 A PL01365072 A PL 01365072A PL 36507201 A PL36507201 A PL 36507201A PL 365072 A1 PL365072 A1 PL 365072A1
Authority
PL
Poland
Prior art keywords
therapeutic agents
fungal infections
azole compounds
azole
compounds
Prior art date
Application number
PL01365072A
Other languages
English (en)
Polish (pl)
Inventor
Ashwani Kumar Verma
Sudershan K. Arora
Jasbir Singh Arora
Ashok Rattan
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN198DE2000 external-priority patent/IN191188B/en
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of PL365072A1 publication Critical patent/PL365072A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL01365072A 2000-03-07 2001-03-01 Azole compounds as therapeutic agents for fungal infections PL365072A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN198DE2000 IN191188B (fr) 2000-03-07 2000-03-07
US09/575,578 US6670363B1 (en) 2000-03-07 2000-05-22 Azole compounds as therapeutic agents for fungal infections
PCT/IB2001/000300 WO2001066551A2 (fr) 2000-03-07 2001-03-01 Composes azole comme agents therapeutiques pour traiter des infections mycosiques

Publications (1)

Publication Number Publication Date
PL365072A1 true PL365072A1 (en) 2004-12-27

Family

ID=26324879

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365072A PL365072A1 (en) 2000-03-07 2001-03-01 Azole compounds as therapeutic agents for fungal infections

Country Status (8)

Country Link
EP (1) EP1278755A2 (fr)
JP (1) JP2004501867A (fr)
AU (1) AU3402301A (fr)
CA (1) CA2402345A1 (fr)
NZ (1) NZ521241A (fr)
PL (1) PL365072A1 (fr)
RU (1) RU2002126272A (fr)
WO (1) WO2001066551A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002044160A1 (fr) * 2000-11-30 2002-06-06 Senju Pharmaceutical Co., Ltd. Medicaments pour lutter contre la pancreatite et produits medicinaux pour prevenir et traiter l'oesophagite peptique
EP1347758A1 (fr) 2000-12-26 2003-10-01 Ranbaxy Laboratories, Ltd. Composes azoliques utilises comme antifongiques
WO2002060446A1 (fr) 2001-01-29 2002-08-08 Shionogi & Co., Ltd. Preparation medicamenteuse contenant du 5-methyle-1-phenyle-2-(1h)-pyridone en tant que principe actif
HUP0303249A3 (en) 2001-02-22 2007-03-28 Sankyo Co Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them
IN192526B (fr) * 2001-09-25 2004-04-24 Ranbaxy Lab
AU2002328176A1 (en) * 2002-08-26 2004-03-11 Ranbaxy Laboratories Limited Azole derivatives as antifungal agents
EP1413301A1 (fr) * 2002-10-24 2004-04-28 Bayer CropScience SA Médicaments antifongiques à base de dérivés d'arylamidine
JPWO2007020888A1 (ja) 2005-08-12 2009-02-26 武田薬品工業株式会社 脳・神経細胞保護剤および睡眠障害治療薬
US9156830B2 (en) 2011-05-17 2015-10-13 Shionogi & Co., Ltd. Heterocyclic compounds
AU2012272804B2 (en) 2011-06-22 2017-07-06 Vyome Therapeutics Limited Conjugate-based antifungal and antibacterial prodrugs
CN102617494B (zh) * 2012-03-15 2014-10-29 南京工业大学 一种含有烯醚结构的三唑类化合物及其制备方法和用途
MX2015016675A (es) 2013-06-04 2016-07-15 Vyome Biosciences Pvt Ltd Particulas recubiertas y composiciones que comprenden las mismas.
BR112016017690A2 (pt) 2014-01-29 2017-08-08 Vyome Biosciences Pvt Ltd Tratamentos para acne resistente
CA2937365C (fr) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Formulation en granules de 5-methyl-1-phenyl-2-(1h)-pyridone et methode de fabrication associee
AR109545A1 (es) 2016-09-29 2018-12-19 Bayer Cropscience Ag Derivados de triazol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW218017B (fr) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
CA2134417A1 (fr) * 1993-12-22 1995-06-23 Katsumi Itoh Derives azotes optiquement actifs leur production et leur utilisation
US5639754A (en) * 1994-07-12 1997-06-17 Janssen Pharmaceutica N.V. Urea and thiourea derivatives of azolones
EP0957101A1 (fr) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Azoles solubles dans l'eau, antifongiques à large spectre

Also Published As

Publication number Publication date
AU3402301A (en) 2001-09-17
WO2001066551A8 (fr) 2003-06-26
WO2001066551A2 (fr) 2001-09-13
RU2002126272A (ru) 2004-08-10
CA2402345A1 (fr) 2001-09-13
WO2001066551A3 (fr) 2002-03-07
JP2004501867A (ja) 2004-01-22
NZ521241A (en) 2004-02-27
EP1278755A2 (fr) 2003-01-29

Similar Documents

Publication Publication Date Title
AU2002221239A1 (en) Therapeutic benzimidazole compounds
IL176151A0 (en) Endoparasiticidal agents for topical application
EP1387680A4 (fr) Agents th rapeutiques base de d riv s benzimidazole
HK1057702A1 (en) Triazole compounds useful as protein kinase inhibitors
AU2001230426A1 (en) Therapeutic morpholino-substituted compounds
IL148719A0 (en) Kinase inhibitors as therapeutic agents
IL153787A0 (en) Imidazole derivatives
EP1432420A4 (fr) Derives de benzimidazolidinone utilises comme agents muscariniques
HK1075619A1 (en) New uses for anti-malarial therapeutic agents
IL159742A0 (en) Azole derivatives useful as insecticide
PL365072A1 (en) Azole compounds as therapeutic agents for fungal infections
AU2002334270A1 (en) Azole derivatives as antifungal agents
GB0118407D0 (en) Oxazolidinone derivatives as antibacterial agents
GB0107751D0 (en) Pharmaceutically active compounds
GB0105893D0 (en) Pharmaceutically active compounds
AU2002253456A8 (en) Azole derivatives as antifungal agents
IL154258A0 (en) Fungicidal formulation
GB0106631D0 (en) Pharmaceutically active compounds
SI1261588T1 (en) IMIDAZOLE COMPOUNDS AS Alpha2-ADRENOCEPTORS ANTAGONISTS
AU2003258983A8 (en) Combinations for the treatment of fungal infections
AU2001262729A1 (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
PL362051A1 (en) Azole compounds as anti-fungals agents
EP1412337A4 (fr) Composes azole en tant qu'agents antifongiques
GB2360705B (en) Anti fungal formulation
AU2002345264A1 (en) Azole compounds as anti-fungal agents

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)